The design and synthesis of novel derivatives of the dopamine uptake inhibitors GBR 12909 and GBR 12935. High-affinity dopaminergic ligands for conjugation with highly fluorescent cadmium selenide/zinc sulfide core/shell nanocrystals

Tetrahedron

Volumn 59, Issue 40, 2003, Pages 8035-8047

  Tomlinson, Ian D ^a   Mason, John ^b   Burton, Jon N ^a   Blakely, Randy ^b   Rosenthal, Sandra J ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cadmium selenide zinc sulfide core shell nanocrystals; Dopamine transporter; Inhibition; Ligand; Thiol

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 11 BROMOUNDECANOIC ACID [4 [3 [4 (2 BENZHYDRYLOXYETHYL)PIPERAZIN 1 YL]PROPYL]PHENYL]AMIDE; 11 MERCAPTOUNDECANOIC ACID [4 [3 [4 [2 (4,4' FLUOROBENZHYDRYLOXY)ETHYL]PIPERAZIN 1 YL]PROPYL]PHENYL]AMIDE; CADMIUM; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; N [4 [3 [4 (2 BENZHYDRYLOXYETHYL)PIPERAZIN 1 YL]PHENYL]]ACETAMIDE; N [4 [3 [4 (2 BENZHYDRYLOXYETHYL)PIPERAZIN 1 YL]PROPYL]PHENYL] 2 [2 (2 MERCAPTOETHOXY)ETHOXY]ACETAMIDE; NANOPARTICLE; PIPERAZINE DERIVATIVE; SELENIDE; THIOL DERIVATIVE; UNCLASSIFIED DRUG; VANOXERINE; ZINC SULFIDE;

ARTICLE; DRUG CONJUGATION; DRUG DESIGN; DRUG SYNTHESIS; FLUORESCENCE; IMAGING SYSTEM; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0141628763     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(03)01179-7     Document Type: Article

References (35)

1. Alivisatos A.P. J. Phys. Chem. 100:1996;13226-13239.
2. Hines M.A., Guyot-Sionnest P. J. Phys. Chem. 100:1996;468-471.
3. Dabbousi B.O., Rodriguez-Viejo J., Mikulec F.V., Heine J.R., Mattoussi H., Ober R., Jensen K.F., Bawendi M.G. J. Phys. Chem. B. 101:1997;9463-9475.
4. Peng X., Schlamp M.C., Kadavanich A.V., Alivisatos A.P. J. Am. Chem. Soc. 119:1997;7019-7029.
5. Bruchez M., Moronne M., Gin P., Weiss S., Alivisatos A.P. Science. 281:1998;2013-2016.
6. Chan W.C.W., Nie S. Science. 281:1998;2016-2018.
7. Chunyang Z., Hui M., Nie S., Yao D., Leland J., Dieyan C. The Analyst. 125:2000;1029.
8. Sondi I., Silman O., Koester S., Matijev E. Langmuir. 16:2000;3107.
9. Tomlinson I.D., Kippeny T., Swafford L., Siddiqui N.H., Rosenthal S.J. J. Chem. Res. (M). 2002;527-539.
10. Rosenthal S.J., Tomlinson I.D., Adkins E.M., Schroeter S., Adams S., Swafford L., McBride J., Wang Y., DeFelice L.J., Blakely R.D. J. Am. Chem. Soc. 124:2002;4586-4594.
11. Xing D., Chen P., Keil R., Kilts C.D., Shi B., Camp V.M., Malveaux G., Ely T., Owens M.J., Votaw J., Davis M., Hoffman J.M., Bakay R.A.E., Subramanian T., Watts R.L., Goodman M.M. J. Med. Chem. 43:2000;639-648.
12. Jiang S., Chang A., Abraham P., Kuhar M.J., Carroll I. Bioorg. Med. Chem. Lett. 8:1998;3689-3692.
13. Zou M., Kpajtic T., Katz J.L., Wirtz S., Justice J.B., Newman H.N. J. Med. Chem. 44:2001;4453-4461.
14. Meltzer P.C., Blundell P., Chen Z., Yong Y.F., Madras B.K. Bioorg. Med. Chem. Lett. 9:1999;857-862.
15. Prakash K.R.C., Tamiz A.P., Araldi G.L., Zhang M., Johnson K.M., Kozikowski A.P. Bioorg. Med. Chem. Lett. 9:1999;3325-3328.
16. Xu C., Coffey L.L., Reith M.E.A. Biochem. Pharmacol. 49:(3):1995;339-350.
17. Zhang Y., Rothman R.B., Dersch C.M., DeCosta B.R., Jacobson A.E., Rice K.C. J. Med. Chem. 43:2000;4840-4849.
18. Lewis D.B., Matecka D., Zhang Y., Hsin L., Dersch C.M., Stafford D., Glowa J.R., Rothman R.B., Rice K.C. J. Med. Chem. 42:1999;5029-5042.
19. Choi S., Elmaleh D.R., Hanson R.N., Fischman A.J. J. Med. Chem. 43:2000;205-213.
20. Rothman R.B., Mele A., Reid A.A., Akunne H.C., Greig N., Thurkauf A., DeCosta B.R., Rice K.C., Pert A. Pharmacol. Biochem. Behav. 40:1991;387-391.
21. Van Der Zee P., Koger H.S., Gootjes J., Hespe W. Eur. J. Med. Chem. 15:(4):1980;363-370.
22. Benedetti P., Mannhold R., Cruciani G., Pastor M. J. Med. Chem. 45:2002;1577-1584.
23. Dutta A.K., Davis M.C., Fei X., Beardsley P.M., Cook C.D., Reith M.E.A. J. Med. Chem. 45:2002;654-662.
24. Matecka D., Lewis D., Rothman R.B., Dersch C.M., Wojnicki F.H.E., Glowa J.R., DeVries A.C., Pert A., Rice K.C. J. Med. Chem. 40:1997;705-716.
25. Zhang Y., Williams W., Torrence-Campbell C., Bowen W.D., Rice K.C. J. Med. Chem. 41:1998;4950-4957.
26. Matecka D., Rothman R.B., Radesca L., DeCosta B.R., Dresch C.M., Partilla J.S., Pert A., Glowa J.R., Wojnicki F.H.E., Rice K.C. J. Med. Chem. 39:1996;4704-4716.
27. Corey E.J., Helal C.J. Tetrahedron Lett. 37:(28):1996;837-4840.
28. Greene T.W. McOmie J.F.W. Protective Groups in Organic Chemistry. 1973;197-198 Plenum, New York.
29. Boden, N.; Bushby, R. J.; Clarson, S.; Knowles, P. F.; Marsh, A. Tetrahedron, 1997, 53 (31), 10939-10952.
30. Boden N., Bushby R.J., Liu Q., Evans S.D., Jenkins T.A., Knowels P.F., Miles R.E. Tetrahedron. 54:1998;11537-11548.
31. Braun M., Camps X., Vostrowsky O., Hirsch A., Endrreb E., Bayler T.M., Birkert O., Gauglitz G. Eur. J. Org. Chem. 2000;1173-1181.
32. Hsin L.W., Dersch C.M., Baumann M.H., Stafford D., Glowa J.R., Rothman R.B., Jacbson A.E., Rice K.C. J. Med. Chem. 45:2002;1321-1329.
33. Buzas A. J. Med. Chem. 23:1980;149-153.
34. Bruchez, M. Private communication.
35. Taylor J., Kippeny T., Rosenthal S.J. J. Cluster Sci. 12:2001;571-583.